• 9534 Citations
  • 40 h-Index
1991 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Karen Kelly is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1992 2021

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health

7/1/026/30/21

Project: Research project

Neoplasms
Organized Financing
Research
Research Personnel
Clinical Trials

SPORE IN LUNG CANCER

Kelly, K., Prochazka, A., Degregori, J. V., Pettijohn, D., Heasley, L., Kane, M., Kazlauskas, A., Drabkin, H. A., Baron, A., Keith, R., Merrick, D. T., Kennedy, T., Gemmill, R., Sclafani, R., Archer, P., Anderson, M., Johnson, G., Stevens, J., Nemenoff, R. A., Franklin, W., Miller, Y. & Bunn, P.

National Institutes of Health

9/30/924/30/19

Project: Research project

Tissue and Organ Procurement
Clinical Trials
Lung Neoplasms
Translational Medical Research
Bombesin

Research Output 1991 2019

Clinical prognostic model for older patients with advanced non-small cell lung cancer

Ganti, A. K., Wang, X., Stinchcombe, T. E., Wang, Y., Bradley, J., Cohen, H. J., Kelly, K., Paulus, R., Ramalingam, S. S., Vokes, E. E. & Pang, H., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Weight Loss
Proportional Hazards Models
ROC Curve

Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non–small-cell Lung Cancer

Al-Obeidi, E., Li, T. & Kelly, K., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Therapeutics
BIBW 2992
Adenocarcinoma of lung
12 Citations (Scopus)

Efficacy and Safety of Avelumab for Patients with Recurrent or Refractory Ovarian Cancer: Phase 1b Results from the JAVELIN Solid Tumor Trial

Disis, M. L., Taylor, M. H., Kelly, K., Beck, J. T., Gordon, M., Moore, K. M., Patel, M. R., Chaves, J., Park, H., Mita, A. C., Hamilton, E. P., Annunziata, C. M., Grote, H. J., Von Heydebreck, A., Grewal, J., Chand, V. & Gulley, J. L., Jan 1 2019, (Accepted/In press) In : JAMA oncology.

Research output: Contribution to journalArticle

Patient Safety
Ovarian Neoplasms
Neoplasms
avelumab
Platinum
Pemetrexed
Cisplatin
Drug Therapy
Disease-Free Survival
Platinum

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review

Abdel Karim, N. & Kelly, K., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Therapeutics
Proto-Oncogenes
Molecular Diagnostic Techniques
Clinical Trials